抗菌敷料预防手术部位感染:系统评价与Meta分析
该系统评价与Meta分析纳入35项RCT共8718例患者,比较抗菌敷料与惰性敷料对闭合手术切口SSI的预防效果。结果显示银敷料和DACC敷料可能降低SSI风险,莫匹罗星敷料无显著预防作用,其他抗菌敷料证据不足。
要点
- 银敷料可能降低SSI风险22%(RR 0.78,95%CI 0.62-0.97),证据确定性中等。
- DACC敷料可能将SSI风险减半(RR 0.49,95%CI 0.29-0.83),证据确定性中等。
- 莫匹罗星敷料未显示SSI预防作用,其他抗菌敷料证据不足。
核心结论
- 银敷料和DACC敷料可能降低闭合手术切口的SSI风险。
- 其他抗菌敷料的临床有效性仍存在不确定性。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Embase、CINAHL和Cochrane CENTRAL自建库至2024年7月5日,并补充灰色文献和引文追溯。
- 纳入比较抗菌敷料与任何惰性敷料用于择期或急诊手术后闭合切口的RCT。
- 共纳入35项RCT,涉及8718例参与者;采用Cochrane RoB 2评估偏倚风险,GRADE评级证据确定性。
主要发现
- 银敷料(21项研究,5504例参与者)与标准敷料相比,SSI风险降低22%(RR 0.78,95%CI 0.62-0.97;I²=43%;中等确定性证据)。
- DACC敷料(3项研究,892例参与者)与标准敷料相比,SSI风险减半(RR 0.49,95%CI 0.29-0.83;I²=0%;中等确定性证据)。
- 莫匹罗星敷料(3项研究,1320例参与者)与SSI预防无关(RR 0.62,95%CI 0.15-2.63;I²=67%;极低确定性证据)。
- 其他抗菌药物的证据不足。
关键数值与推荐
- 主要结局为30天内SSI(若使用假体则为90天内)。
- 次要结局包括不良事件和费用。
临床怎么用
- 对于闭合手术切口,可考虑使用银敷料或DACC敷料以降低SSI风险。
- 莫匹罗星敷料不推荐用于SSI预防。
- 其他抗菌敷料的常规使用尚缺乏充分证据支持。
局限性
- 其他抗菌敷料的证据不足,无法得出明确结论。
- 莫匹罗星敷料的证据确定性极低。
- 部分Meta分析存在中至高度异质性(如银敷料I²=43%,莫匹罗星I²=67%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical-site infections (SSIs) are a leading cause of postoperative morbidity, prolonged hospitalization, and significant healthcare costs. Antimicrobial dressings may mitigate SSI risk by minimizing local microbial burden, but their effectiveness remains uncertain. METHODS: MEDLINE, Embase, CINAHL, and Cochrane CENTRAL were searched from inception up to 5 July 2024, supplemented by searches of the grey literature and citation chasing. RCTs comparing antimicrobial dressings with any other inert dressing for closed incisional wounds after elective or emergency surgery were included. Data were extracted in duplicate, risk of bias (RoB) was assessed using the Cochrane RoB 2 tool, and certainty of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool. Pairwise random-effects meta-analyses were performed. The primary outcome was SSI within 30 days (90 days if prosthesis used); secondary outcomes included adverse events and costs. RESULTS: A total of 35 RCTs involving 8718 participants were included. Meta-analyses were conducted for silver (21 studies, 5504 participants), dialkylcarbamoyl chloride (DACC) (3 studies, 892 participants), and mupirocin (3 studies, 1320 participants). Compared with standard dressings, silver dressings reduced the risk of SSI by 22% (risk ratio (RR) 0.78 (95% c.i. 0.62 to 0.97); I2 = 43%; moderate-certainty evidence). DACC dressings halved the risk of SSI (RR 0.49 (95% c.i. 0.29 to 0.83); I2 = 0%; moderate-certainty evidence) compared with standard dressings. Mupirocin dressings were not associated with SSI prevention (RR 0.62 (95% c.i. 0.15 to 2.63); I2 = 67%; very low-certainty evidence). Evidence for other agents was insufficient. CONCLUSION: Silver and DACC dressings probably reduce the risk of SSI in closed surgical wounds. There is residual uncertainty over the clinical effectiveness of other antimicrobial dressings. Surgical wounds sometimes become infected, which can delay healing, and need extra treatment. Many hospitals use antimicrobial dressings to try to prevent infections, but it has been unclear how well they work and if they are worth the cost. Thirty-five clinical trials involving over 8700 patients were reviewed to compare these dressings with standard dressings. It was found that silver and dialkylcarbamoyl chloride (DACC) dressings probably reduce the risk of infection, while the evidence for other antimicrobial dressings was unclear. Side effects were rare. Overall, certain antimicrobial dressings appear helpful, but stronger research is still needed to guide routine use and ensure good value.
引用
- Yusuf SM, James J, Chong B, et al. Antimicrobial dressings for the prevention of surgical-site infection: systematic review and meta-analysis. Br J Surg. 2026. PMID: 41677813. doi:10.1093/bjs/znaf277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。